Catechol O-Methyltransferase: Characterization of the Protein, Its Gene, and the Preclinical Pharmacology of COMT Inhibitors

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 324-328

  Männistö, Pekka T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956730175     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60755-3     Document Type: Article

References (5)

1. Männistö P.T., Ulmanen I., Lundström K., Taskinen J., Tenhunen J., Tilgmann C., and Kaakkola S. Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog. Drug. Res. 39 (1992) 291-350
2. Kaakkola S., Gordin A., and Männistö P.T. General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase (COMT). Gen. Pharmacol. 25 (1994) 813-824
3. Männistö P.T., Tuomainen P., and Tuominen R.K. Different in vivo properties of three new inhbitors of catechol O-methyltransferase in the rat. Br. J. Pharmacol. 105 (1992) 569-574
4. Männistö P.T., and Kaakkola S. New selective COMT inhibitors: Useful adjuncts for Parkinson's disease. Trends Pharmacol. Sci. 10 (1989) 54-56
5. Törnwall M., and Männistö P.T. Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur. J. Pharmacol. 250 (1993) 77-84